6 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 19646194 | Effects of rosiglitazone and pioglitazone on lipoprotein metabolism in patients with Type 2 diabetes and normal lipids. | 2009 May | 1 |
2 | 18413496 | Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus. | 2008 Apr 22 | 1 |
3 | 17229249 | Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin. | 2007 Feb | 1 |
4 | 16644631 | Improvement of glycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual (alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with metformin monotherapy: A double-blind, randomized, pioglitazone-comparative study. | 2006 May | 1 |
5 | 12809958 | A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus. | 2003 Apr | 1 |
6 | 12466345 | Effects of pioglitazone in nondiabetic patients with arterial hypertension: a double-blind, placebo-controlled study. | 2002 Dec | 1 |